- Home
- HTLD vs ALVO Comparison
HTLD vs ALVO Comparison
Compare HTLD & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HTLD | ALVO |
|---|---|---|
| Founded | 1978 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HTLD | ALVO |
|---|---|---|
| Price | $11.62 | $5.84 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $11.50 | $8.00 |
| AVG Volume (30 Days) | 596.4K | ★ 1.1M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.60% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $805,709,000.00 | N/A |
| Revenue This Year | N/A | $13.28 |
| Revenue Next Year | $8.36 | $18.63 |
| P/E Ratio | $166.29 | ★ $18.20 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.00 | $2.94 |
| 52 Week High | $16.64 | $9.05 |
Technical Indicators
Market Signals| Indicator | HTLD | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 35.30 | 75.71 |
| Support Level | $10.67 | $3.10 |
| Resistance Level | $12.13 | $5.85 |
| Average True Range (ATR) | 0.42 | 0.25 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 14.93 | 86.64 |
Price Performance
Historical ComparisonAbout HTLD Heartland Express Inc.
Heartland Express Inc, along with its subsidiaries, operates as a short, medium, and long-haul truckload carrier and transportation services provider. It mainly provides nationwide asset-based dry van truckload service for shippers across the United States, along with cross-border freight and other transportation services offered through third-party partnerships in Mexico. The group operates under the brand names of Heartland Express, Millis Transfer, Smith Transport, and CFI (for services within Mexico).
About ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.